Search Results - "Dabbeche, S"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Thromboembolic Events and COVID-19 Vaccine by Kammoun, R, Dabbeche, S, Charfi, O, Daly, W, Daghfous, R, Aidli, S E

    Published in Drug safety (01-10-2022)
    “…Introduction: Thromboembolic events (TE) are a major source of morbidity and mortality. Several risk factors have been associated to this condition such as age…”
    Get full text
    Journal Article
  2. 2

    Secondary Depression Associated to TNF-a Inhibitors by Jabri, F E, Kastalli, S, Kaabi, W, Dabbeche, S, Daghfous, R, Aidi, S E

    Published in Drug safety (01-10-2022)
    “…Introduction: A number of adverse drug reactions are known to be associated with Anti TNF alpha drugs; they include infections, injection site reactions, liver…”
    Get full text
    Journal Article
  3. 3

    Fixed Drug Eruption after ChAdOx1 nCoV-19 Vaccine by Jabri, F E, Kastalli, S, Ferchichi, K, Dabbeche, S, Daghfous, R, Aidli, S E

    Published in Drug safety (01-10-2022)
    “…Introduction: ChAdOx1 nCoV-19 vaccine is an adenoviral-vectored COVID-19 vaccine. The most common side effects are headache, muscle pain, redness, swelling,…”
    Get full text
    Journal Article
  4. 4

    Oxybutynin Induced Blindness in a Child by Daldoul, M, Zaiem, A, Mahjoubi, Y, Dabbeche, S, Hamza, I, Daghfous, R, Kastalli, S, Aidli, S E

    Published in Drug safety (01-10-2022)
    “…Introduction: Oxybutynin is an anticholinergic and a spasmolytic drug used as a therapeutic option in patients with overactive detrusor function-either…”
    Get full text
    Journal Article